featured
Effect of Treatment With Empagliflozin on Hepatic Steatosis in Patients With MASLD Without Diabetes Mellitus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
Hepatology 2024 Oct 01;80(4)916-927, KS Cheung, HY Ng, RWH Hui, LK Lam, LY Mak, YC Ho, JT Tan, EW Chan, WK Seto, MF Yuen, WK LeungFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.